MACRO Consulting Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2M Buy
17,288
+117
+0.7% +$13.6K 1.03% 40
2021
Q1
$2.06M Sell
17,171
-249
-1% -$29.5K 1.11% 31
2020
Q4
$1.91M Buy
17,420
+193
+1% +$21K 1.11% 31
2020
Q3
$1.81M Sell
17,227
-5,675
-25% -$576K 1.19% 27
2020
Q2
$2.1M Sell
22,902
-177
-0.8% -$16K 1.46% 14
2020
Q1
$2.17M Buy
23,079
+1,079
+5% +$90K 1.66% 13
2019
Q4
$1.91M Buy
22,000
+859
+4% +$71.9K 1.51% 19
2019
Q3
$1.77M Buy
21,141
+172
+0.8% +$14.6K 1.51% 20
2019
Q2
$1.76M Sell
20,969
-1,512
-7% -$119K 1.51% 16
2019
Q1
$1.8M Sell
22,481
-3,603
-14% -$268K 1.72% 14
2018
Q4
$1.89M Buy
+26,084
New +$1.83M 1.84% 12

Other funds holding ABT

MACRO Consulting Group's ABT Position: Q2 2021 in Review

MACRO Consulting Group increased its Abbott (ABT) stake by 0.68% in Q2 2021, buying an estimated $13.6K and bringing the position to 17,288 shares worth $2M. The position accounts for 1.03% of the portfolio, ranked #40.

MACRO Consulting Group first reported a position in ABT in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.17M in Q1 2020. 2,504 funds tracked by Wall St. Rank hold ABT as of Q2 2021.

  • MACRO Consulting Group held 17,288 shares of Abbott worth $2M as of Q2 2021.
  • MACRO Consulting Group bought 117 Abbott shares in Q2 2021, an estimated $13.6K.
  • Abbott made up 1.03% of MACRO Consulting Group's portfolio in Q2 2021, its #40 holding.
  • MACRO Consulting Group first reported a position in Abbott in Q4 2018 and has held it in 11 quarters since.
  • MACRO Consulting Group's Abbott position peaked at $2.17M in Q1 2020.
  • 2,504 funds tracked by Wall St. Rank held Abbott as of Q2 2021.

Based on MACRO Consulting Group's 13F filing for Q2 2021, filed 16 Aug 2021.